Prebionature Protect Women's health 15B
Prebionature Protect Women's health 15B, NPN 80112723: natural health product licensed in Canada. Medicinal ingredients: Lactobacillus rhamnosus, Lactobacillus acidophilus.
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Lactobacillus rhamnosus Source : Lactobacillus rhamnosus - Cellule entière | 6 Milliards d'UFC | Not calculated |
| Lactobacillus rhamnosus Source : HN001 | 6 Milliards d'UFC | Not calculated |
| Lactobacillus acidophilus Source : La-14 | 9 Milliards d'UFC | Not calculated |
| Lactobacillus acidophilus Source : Lactobacillus acidophilus - Cellule entière | 9 Milliards d'UFC | Not calculated |
Non-medicinal ingredients
Chlorure de sodium, Trehalose, Hydrogénophosphate de dipotassium, Phosphate de potassium monobasique, Hypromellose, Dioxyde de silicium, Stéarate de magnésium, Sucrose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Helps support intestinal/gastrointestinal health. Source of Probiotics. Helps restore and maintain healthy vaginal flora.Helps support vaginal health.Helps maintain vaginal microbiota balance.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contra-Indications
Do not use this product if you have an immune-compromised condition (e.g. AIDS, lymphoma, patients undergoing long-term corticosteroid treatment).
Product record
- Other names
- Prebionature Women's health 15 B
- Licence holder
- Prébionature Inc.
- NPN or DIN-HM
- 80112723
- Status
- Active licence
- Licence date
- 8 September 2021
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
Source
Official Health Canada record, licence 80112723
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Prebionature Protect Women's health 15B: composition and ingredients”, https://compoatlas.com/en/supplements/canada/80112723-prebionature-protect-women-s-health-15b, updated 8 September 2021.